Rachel Martini

Rachel Martini

Cornell University

H-index: 9

North America-United States

About Rachel Martini

Rachel Martini, With an exceptional h-index of 9 and a recent h-index of 9 (since 2020), a distinguished researcher at Cornell University, specializes in the field of breast cancer genetics and genomics, health disparities.

His recent articles reflect a diverse array of research interests and contributions to the field:

Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment

Abstract C010: Genes with African ancestry-specific expression in TNBC tumors also show population-specific baseline differences in normal mammary tissue

Abstract C009: Race-and TNBC-specific circulating biomarker profiles among breast cancer patients

Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling

Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identifies essential kinases and synergy of EGFR and FGFR1 inhibition.

MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans

African ancestry–associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent

DARC/ACKR1 expression is associated with immune landscape changes among triple negative breast tumors

Rachel Martini Information

University

Position

Graduate Research Assistant, University of Georgia; Visiting Graduate Assistant, Weill Cornell Medical College

Citations(all)

317

Citations(since 2020)

317

Cited By

59

hIndex(all)

9

hIndex(since 2020)

9

i10Index(all)

9

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Rachel Martini Skills & Research Interests

breast cancer genetics and genomics

health disparities

Top articles of Rachel Martini

Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment

Cancer Letters

2024/3/1

Abstract C010: Genes with African ancestry-specific expression in TNBC tumors also show population-specific baseline differences in normal mammary tissue

2023/1/1

Abstract C009: Race-and TNBC-specific circulating biomarker profiles among breast cancer patients

2023/1/1

Rachel Martini
Rachel Martini

H-Index: 4

Melissa Davis
Melissa Davis

H-Index: 3

Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling

Cancers

2023/4/13

Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identifies essential kinases and synergy of EGFR and FGFR1 inhibition.

2024/1/31

MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans

Scientific Reports

2022/12/22

African ancestry–associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent

Cancer discovery

2022/11/2

DARC/ACKR1 expression is associated with immune landscape changes among triple negative breast tumors

Cancer Research

2022/6/15

Whole genome sequence of triple negative breast cancer (TNBC) tumors of African descent

Cancer Research

2022/6/15

Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility

Cancer Discovery

2022/6/2

Rachel Martini
Rachel Martini

H-Index: 4

Understanding how genetic ancestry may influence cancer development

2022/4/1

Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studies

EBioMedicine

2022/3/1

Abstract PO-141: The role of African Duffy-null allele related inflammation on the tumor microenvironment

Cancer Epidemiology, Biomarkers & Prevention

2022/1/1

Abstract PO-139: BRCA sequence variants in breast cancer patients with African ancestry

Cancer Epidemiology, Biomarkers & Prevention

2022/1/1

Cancer microenvironment and genomics: evolution in process

2022/2

Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity

2021/5/5

Rachel Martini
Rachel Martini

H-Index: 4

Melissa Davis
Melissa Davis

H-Index: 3

Development of Empirical Dietary Inflammatory Pattern (EDIP) scores with Different Food Groups and Biomarkers

Columbia Undergraduate Research Journal

2021/5/5

Rachel Martini
Rachel Martini

H-Index: 4

Melissa Davis
Melissa Davis

H-Index: 3

Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort

Scientific reports

2021/4/29

Social and clinical determinants of COVID-19 outcomes: modeling real-world data from a pandemic epicenter

medRxiv

2021/4/7

Abstract SS1-07: Gene expression profiles of Ghanaian and Ethiopian triple-negative breast tumors

Cancer Research

2021/2/15

See List of Professors in Rachel Martini University(Cornell University)